Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HanAll Biopharma Reports Full-Year 2022 Results and Provides Business Update 2023-02-01 20:00
Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers 2023-02-01 15:00
CARsgen Announces Collaboration Agreement to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer 2023-01-31 21:50
Appendix 4C - Q2 FY23 Quarterly Cash Flow Report 2023-01-31 20:25
Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic 2023-01-31 16:10
Singleron to present single cell sequencing solutions at the 36th Molecular Biology of Plants Conference 2023-01-31 16:00
Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic Pulmonary Fibrosis in the Greater China Region 2023-01-31 14:43
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology 2023-01-31 09:24
Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of Type 2 Diabetes in China 2023-01-31 08:00
Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC 2023-01-31 05:37
Help Therapeutics Announces IND Approval of First Universal iPSC-derived Cardiomyocyte Therapy for End-stage Heart Failure in China 2023-01-30 23:00
Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer 2023-01-30 20:39
Duoning Headquarters in Fengxian Biotechnology Park with Centers for R&D and Technology Applications 2023-01-30 18:00
MGI Makes its Mark in Dubai with Latest Platforms at MEDLAB Middle East and Arab Health 2023-01-30 16:00
Kalbe Consumer Health Crowned Winner at the Asia Pacific Enterprise Awards 2022 Regional Edition 2023-01-30 11:26
Abbisko Therapeutics announces that US FDA has granted breakthrough therapy designation for its CSF-1R inhibitor Pimicotinib(ABSK021) 2023-01-30 11:00
Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases 2023-01-30 10:00
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs 2023-01-27 20:00
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results 2023-01-27 14:52
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease 2023-01-27 08:46
1 90.5 91.5 92.5 93.5 94.5 415